Àڱ󻸷Áõ Ä¡·á ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Endometriosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1822608
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 107 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,872,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,573,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,832,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àڱ󻸷Áõ Ä¡·á ¼¼°è ½ÃÀåÀº 2024³â¿¡ 17¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2034³â¿¡´Â CAGR 13.1%·Î ¼ºÀåÇØ 56¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±³À° ¹× Á¶±â Áø´Ü¿¡ ´ëÇÑ ³ë·ÂÀÌ °­È­µÊ¿¡ µû¶ó Á¶±â¿¡ ÀÇ·á °³ÀÔÀ» ¿ä±¸ÇÏ´Â »ç¶÷ÀÌ ´Ã¾î³ª È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ç°­ °ü¸® Á¦°ø¾÷ü´Â ´çºÐ°£ÀÇ Áõ»ó ¿ÏÈ­»Ó¸¸ ¾Æ´Ï¶ó Àå±âÀûÀÎ °Ç°­ °á°úÀÇ °³¼±µµ ½Ã¾ß¿¡ ³ÖÀº Á¾ÇÕÀûÀÎ °ü¸® Àü·«¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¿ËÈ£ ´Üü´Â ´õ ¸¹Àº ¿©¼ºµé¿¡°Ô Ä¡·á ¿É¼ÇÀ» ¿ä±¸Çϵµ·Ï Ã˱¸Çϰí ÀÌ º´Å¸¦ ½ºÆ¼±×¸¶È­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ëµµ Ä¡·á ¿É¼ÇÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, Á¦¾à ȸ»ç´Â ȯÀÚÀÇ Ä¡·á¸¦ Çâ»ó½ÃŰ´Â Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù.

Àڱ󻸷Áõ Ä¡·á Market-IMG1

°Ç°­ °ü¸® ÁöÃâ Áõ°¡¿Í º¸Çè Àû¿ë °³¼±À¸·Î Àڱà ³»¸·Áõ Ä¡·á°¡ ´õ Ä£¼÷ÇØÁ³°í, ´õ ¸¹Àº ȯÀÚ°¡ Àû½Ã¿¡ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Ä¡·áµÇÁö ¾ÊÀº Àڱ󻸷ÁõÀÌ Àå±âÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù´Â °ÍÀ» °­Á¶ÇÏ´Â °è¹ß Ä·ÆäÀÎÀÌ °è¼ÓµÇ´Â °¡¿îµ¥, Àü¹®ÀûÀÎ Ä¡·á¸¦ ¿ä±¸Çϴ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ƯÈ÷ ¼ö¼úÀû °³ÀÔÀ» ´ëüÇÒ °ÍÀ» ¿ä±¸ÇÏ´Â ÀþÀº ȯÀÚµé »çÀÌ¿¡¼­ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾî Àü¹®°¡´Â °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ´Â °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù¹ýÀÇ ÅëÇÕÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç ½ÃÀåÀ» ´õ¿í ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀå ±Ô¸ð 17¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 56¾ï ´Þ·¯
CAGR 13.1%

Áúº´ À¯Çüº°·Î º¸¸é ½ÃÀåÀº ´Ù¾çÇÑ ÇüÅ·Π±¸ºÐµÇ¸ç, 2024³â¿¡´Â Ç¥À缺 º¹¸· Àڱ󻸷ÁõÀÌ 41.3%ÀÇ ¾ÐµµÀû Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. º¹¸· Ç¥¸éÀÇ º´º¯À» Ư¡À¸·Î ÇÏ´Â ÀÌ º´ÇüÀº º¸´Ù ±íÀº º´ÇüÀÇ Àڱ󻸷Áõº¸´Ù ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ½Äº°ÀÌ ¿ëÀÌÇÕ´Ï´Ù. ±× °á°ú, º¸´Ù ÀÚÁÖ Áø´ÜµÇ°í, ½Å¼ÓÇÑ ÀÇ·á °³ÀÔÀ¸·Î À̾îÁ®, ÀÌ ÇüŸ¦ ´ë»óÀ¸·Î ÇÑ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Ç¥À缺 º¹¸· Àڱà ³»¸·ÁõÀ» Á¶±â¿¡ ¹ß°ßÇÏ°í °ü¸®ÇÒ ¼ö Àֱ⠶§¹®¿¡ ½ÃÀå¿¡¼­ °¡Àå º¸±ÞµÇ´Â ºÎ¹®À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Àڱ󻸷Áõ Ä¡·á ¿É¼ÇÀº ÁַΠȣ¸£¸ó ¿ä¹ý°ú ÅëÁõ °ü¸®·Î ³ª´µ¸ç, È£¸£¸ó ¿ä¹ýÀº 2024³â 8¾ï 290¸¸ ´Þ·¯¸¦ âÃâÇß½À´Ï´Ù. ÀÇ»ç´Â °ñ¹Ý ÅëÁõ°ú ¿ù°æ ÃâÇ÷ °ú´ÙÁõ°ú °°Àº Áõ»óÀ» ¿ÏÈ­Çϱâ À§ÇØ ÇÇÀÓ¾à, Ȳü È£¸£¸ó ¹× È£¸£¸ó Á¶ÀýÁ¦¸¦ ó¹æÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á´Â È¿´É, Åõ¿© ¿ëÀ̼º, ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â ´É·Â¿¡¼­ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ħ½ÀÀûÀÎ Ä¡·á¸¦ ÇÊ¿ä·Î ÇÏÁö ¾Ê°í Áõ»óÀ» ¿ÏÈ­ÇÒ ¼ö Àֱ⠶§¹®¿¡ È£¸£¸ó ¿ä¹ýÀ» ¼±ÅÃÇÏ´Â »ç¶÷ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ Àڱ󻸷Áõ Ä¡·á ½ÃÀåÀº 2024³â¿¡ 5¾ï 8,210¸¸ ´Þ·¯¸¦ Â÷ÁöÇØ, °øÁß À§»ýÀÇ ´ëó³ª °è¹ß Ä·ÆäÀÎ Áõ°¡°¡ ±× ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. Àڱà ³»¸·ÁõÀÇ Áõ»ó°ú ¿µÇâ¿¡ ´ëÇØ °³ÀÎÀ» ±³À°ÇϱâÀ§ÇÑ ³ë·ÂÀº Àû±ØÀûÀÎ °Ç°­ °ü¸® °áÁ¤À» ÃËÁøÇϰíÀÌ »óŸ¦ µÑ·¯½Ñ Æí°ßÀ» ÁÙÀÔ´Ï´Ù. ÀÇÇÐ ¿¬±¸ÀÇ Áøº¸, ¸®ÇÁ·Î´öƼºê Çコ¿¡ ÁßÁ¡È­, Àü¹® ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀº ½ÃÀå È®´ë¸¦ ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Áõ°¡Çϰí ÀÖ´Â °¡¿îµ¥, Á¦¾à ȸ»ç¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â º¸´Ù ¼±ÁøÀûÀ̰í Ä¡¹ÐÇÑ Ä¡·á Á¢±Ù¹ýÀ» ÅëÇØ ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀåÃßÁ¤ ¹× ¿¹Ãø : º´À¯Çüº°, 2021-2034

Á¦6Àå ½ÃÀåÃßÁ¤ ¹× ¿¹Ãø : Ä¡·áÀ¯Çüº°, 2021-2034

Á¦7Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ¾àÁ¦ µî±Þº°, 2021-2034

Á¦8Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Åõ¿© °æ·Îº°, 2021-2034

Á¦9Àå ½ÃÀåÃßÁ¤ ¹× ¿¹Ãø : À¯Åëä³Îº°, 2021-2034

Á¦10Àå ½ÃÀåÃßÁ¤ ¹× ¿¹Ãø : Áö¿ªº°, 2021-2034

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Endometriosis Treatment Market, valued at USD 1.7 billion in 2024 and is estimated to grow at a CAGR of 13.1% to reach USD 5.6 billion by 2034, driven by rising awareness, advances in medical treatments, and improved healthcare accessibility. Increased education and early diagnosis efforts are helping more individuals seek medical intervention at earlier stages, boosting demand for effective therapeutic solutions. Healthcare providers are focusing on comprehensive management strategies that not only address immediate symptom relief but also improve long-term health outcomes. Government initiatives and advocacy groups are playing a critical role in destigmatizing the condition, encouraging more women to pursue treatment options. The growing investment in research and development is also contributing to the expansion of treatment choices, with pharmaceutical companies exploring innovative therapies to enhance patient care.

Endometriosis Treatment Market - IMG1

Rising healthcare expenditure and improved insurance coverage have made endometriosis treatments more accessible, allowing more patients to receive timely medical attention. As awareness campaigns continue to highlight the long-term impact of untreated endometriosis, an increasing number of patients are seeking specialized care. The demand for non-invasive treatment options has surged, particularly among younger patients looking for alternatives to surgical interventions. Healthcare professionals are working to integrate personalized treatment approaches that cater to individual patient needs, further driving the market forward.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.7 Billion
Forecast Value$5.6 Billion
CAGR13.1%

By disease type, the market is segmented into different forms, with the superficial peritoneal endometriosis segment holding a dominant 41.3% share in 2024. This form of the condition, characterized by lesions on the peritoneal surface, is widespread and more easily identifiable than deeper forms of endometriosis. As a result, it is diagnosed more frequently, leading to quicker medical intervention and higher demand for treatments targeting this type. The ability to detect and manage superficial peritoneal endometriosis early has positioned it as the most prevalent segment within the market.

Endometriosis treatment options are primarily divided into hormone therapy and pain management, with hormone therapy generating USD 802.9 million in 2024. Physicians commonly prescribe contraceptives, progestins, and hormone-modulating drugs to alleviate symptoms such as pelvic pain and excessive menstrual bleeding. These treatments are gaining popularity due to their effectiveness, ease of administration, and ability to improve patients' quality of life. More individuals are opting for hormone-based therapies as they provide symptom relief without the need for invasive procedures.

The United States endometriosis treatment market accounted for USD 582.1 million in 2024, fueled by increasing public health initiatives and awareness campaigns. Efforts to educate individuals about the symptoms and implications of endometriosis have encouraged proactive healthcare decisions and reduced stigma surrounding the condition. Advancements in medical research, a stronger focus on reproductive health, and improved access to specialized healthcare services are further accelerating market expansion. As demand for innovative treatment solutions continues to grow, pharmaceutical companies and healthcare providers are working to enhance patient outcomes through more advanced and targeted therapeutic approaches.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Drug Class, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 11 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â